ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Integrating network pharmacology and experimental validation to clarify the anti-hyperuricemia mechanism of cortex phellodendri in mice

Xu, Lieqiang; Cheng, Juanjuan; Lu, Jieyi; Lin, Guoshu; Yu, Qiuxia; Li, Yucui; Chen, Jiannan; Xie, Jianhui; Su, Ziren*; Zhou, Qi*广州中医药大学; 江西农业大学
Frontiers in Pharmacology2022-11-10DOI: 10.3389/fphar.2022.964593
4被引31阅读
引用收藏
分享

摘要

Hyperuricemia (HUA), a common metabolic disease, is treated as the second-largest metabolic disease after diabetes in China. Cortex Phellodendri (CP) is one of the most frequently used herbal medicines for treating gout or HUA. However, the mechanism underlying the anti-HUA effect of CP is still unrevealed. Hence, this study aimed to explore the pharmacological mechanism of CP against HUA using network pharmacology coupled with in vivo experimental validation. Active compounds and potential targets of CP, as well as the potential targets related to HUA, were retrieved from multiple open-source databases. The drug-disease overlapping targets were obtained by Venn diagram analysis and used to construct the herb-component-target (HCT), protein-protein-interaction (PPI), and component-target-pathway (CTP) networks. The functional enrichment analysis was also performed for further study. Furthermore, a HUA mouse model was induced by a combination of intraperitoneal injection of potassium oxonate (PO, 300 mg/kg) and intragastric administration of hypoxanthine (HX, 300 mg/kg) daily for 10 days. Different dosages of CP (200, 400, and 800 mg/kg) were orally given to mice 1 h after modeling. The results showed that 12 bioactive compounds and 122 drug-disease overlapping targets were obtained by matching 415 CP-related targets and 679 HUA-related targets, and berberine was one of the most important compounds with the highest degree value. The core targets of CP for treating HUA were TP53, MAPK8, MAPK3, IL-6, c-Jun, AKT1, xanthine oxidase (XOD), and ATP-binding cassette subfamily G member 2 (ABCG2). The Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment results showed that the anti-HUA effect of CP mainly involved the pathways of inflammation and apoptosis, such as PI3K/Akt, TNF, MAPK, TLR, AMPK, NF-kappa B, and NLRP3 signaling pathways. In vivo animal experiment further confirmed the hypouricemic effect of CP in a HUA mouse model, as evidenced by significantly restored kidney histological deteriorations, and considerably decreased levels of serum uric acid (sUA), creatinine (Cre), blood urea nitrogen (BUN), and hepatic UA. Furthermore, the hypouricemic action of CP in vivo might be attributed to its suppression of XOD activity in the liver, rather than ABCG2 in the kidney. Real-time qPCR (RT-qPCR) and Western blot analysis also confirmed the key roles of the hub genes in CP against HUA. In conclusion, CP exhibited therapeutic effect against HUA via multi-compounds, multi-targets, and multi-pathways. It possessed anti-HUA and nephroprotective effects via suppressing XOD activity, and reversed the progression of renal injury by exerting anti-inflammatory and anti-apoptotic effects.

学科与关键词

关键词
Cortex Phellodendrihyperuricemianetwork pharmacologyberberinexanthine oxidase
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2022-11-10
卷期
第 13 卷
页码
964593
DOI
10.3389/fphar.2022.964593
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China; Natural Science Foundation of Guangdong Province; Guangdong Basic and Applied Basic Research; [82074082]; [2022A1515011706]; [2021B1515140003]

作者

  • X

    Xu, Lieqiang (第一作者)

    jiangxi agr univ

  • C

    Cheng, Juanjuan

    guangzhou univ chinese med

查看全部 10 位作者收起作者
  • L

    Lu, Jieyi

    guangzhou univ chinese med

  • L

    Lin, Guoshu

    guangzhou univ chinese med

  • Y

    Yu, Qiuxia

    2 · guangzhou univ chinese med

  • L

    Li, Yucui

    guangzhou univ chinese med

  • C

    Chen, Jiannan

    guangzhou univ chinese med

  • X

    Xie, Jianhui

    2 · guangzhou univ chinese med

  • S

    Su, Ziren (通讯)

    guangzhou univ chinese med

  • Z

    Zhou, Qi (通讯)

    guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417